Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jana R Jenquin

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|August 21, 2019
Mitigating RNA Toxicity in Myotonic Dystrophy using Small MoleculesKaalak Reddy, Jana R Jenquin, John D Cleary, et al.
ACS Pharmacology & Translational Science|September 6, 2019
Combination Treatment of Erythromycin and Furamidine Provides Additive and Synergistic Rescue of Mis-Splicing in Myotonic Dystrophy Type 1 ModelsJana R Jenquin, Hongfen Yang, Robert W Huigens, et al.
ACS Chemical Biology|August 18, 2018
Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple MechanismsJana R Jenquin, Leslie A Coonrod, Quinn A Silverglate, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 2, 2019
A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levelsKaalak Reddy, Jana R Jenquin, Ona L McConnell, et al.
Iscience|April 28, 2022
Molecular characterization of myotonic dystrophy fibroblast cell lines for use in small molecule screeningJana R Jenquin, Alana P O'Brien, Kiril Poukalov, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|August 21, 2019
Mitigating RNA Toxicity in Myotonic Dystrophy using Small MoleculesKaalak Reddy, Jana R Jenquin, John D Cleary, et al.
ACS Pharmacology & Translational Science|September 6, 2019
Combination Treatment of Erythromycin and Furamidine Provides Additive and Synergistic Rescue of Mis-Splicing in Myotonic Dystrophy Type 1 ModelsJana R Jenquin, Hongfen Yang, Robert W Huigens, et al.
ACS Chemical Biology|August 18, 2018
Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple MechanismsJana R Jenquin, Leslie A Coonrod, Quinn A Silverglate, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 2, 2019
A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levelsKaalak Reddy, Jana R Jenquin, Ona L McConnell, et al.
Iscience|April 28, 2022
Molecular characterization of myotonic dystrophy fibroblast cell lines for use in small molecule screeningJana R Jenquin, Alana P O'Brien, Kiril Poukalov, et al.
Pageof 1